UXI vs. CURE

Last updated Jun 13, 2026

UXI (ProShares Ultra Industrials) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both Leveraged Equities funds - UXI tracks the Dow Jones U.S. Industrials Index (200%) while CURE tracks the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, UXI returned 19.65%/yr vs 13.49%/yr for CURE. A 0.59 correlation means they provide meaningful diversification when combined. UXI charges 0.95%/yr vs 1.08%/yr for CURE.

Performance

UXI vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra Industrials (UXI) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, UXI achieves a 23.82% return, which is significantly higher than CURE's -7.96% return. Over the past 10 years, UXI has outperformed CURE with an annualized return of 19.65%, while CURE has yielded a comparatively lower 13.49% annualized return.

UXI

• 1D: 0.84%
• 1M: 1.14%
• YTD: 23.82%
• 6M: 21.89%
• 1Y: 44.03%
• 3Y*: 33.12%
• 5Y*: 12.39%
• 10Y*: 19.65%

CURE

• 1D: -0.55%
• 1M: 13.71%
• YTD: -7.96%
• 6M: -6.00%
• 1Y: 28.51%
• 3Y*: 3.05%
• 5Y*: 1.51%
• 10Y*: 13.49%

*Multi-year figures are annualized to reflect compound growth (CAGR)

UXI vs. CURE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
UXI ProShares Ultra Industrials	23.82%	28.84%	26.48%	27.34%	-32.90%	34.64%	16.37%	67.44%	-28.13%	51.81%
CURE Direxion Daily Healthcare Bull 3x Shares	-7.96%	22.55%	-8.47%	-9.40%	-20.51%	88.30%	5.02%	55.66%	2.82%	69.32%

Correlation

The correlation between UXI and CURE is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.39
Correlation (3Y) Calculated over the trailing 3-year period	0.49
Correlation (5Y) Calculated over the trailing 5-year period	0.57
Correlation (10Y) Calculated over the trailing 10-year period	0.58
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011	0.59

Over the past year, the correlation between UXI and CURE has dropped to 0.39 - well below their long-term average of 0.59, suggesting their price drivers have been diverging.

UXI vs. CURE - Sectors Allocation Comparison

Sectors	UXI	CURE
Industrials	56.8%	-
Utilities	3.0%	-
Technology	2.4%	-
Consumer Cyclical	0.3%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	-
Healthcare	-	100.0%
Real Estate	-	-

Return for Risk

UXI vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UXI

UXI Risk / Return Rank: 41
UXI Sharpe Ratio Rank: 41
UXI Sortino Ratio Rank: 41
UXI Omega Ratio Rank: 38
UXI Calmar Ratio Rank: 40
UXI Martin Ratio Rank: 43

CURE

CURE Risk / Return Rank: 21
CURE Sharpe Ratio Rank: 20
CURE Sortino Ratio Rank: 24
CURE Omega Ratio Rank: 22
CURE Calmar Ratio Rank: 22
CURE Martin Ratio Rank: 19

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UXI vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Industrials (UXI) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	UXI	CURE	Difference
Sharpe ratio: Return per unit of total volatility	1.29	0.60	+0.69
Sortino ratio: Return per unit of downside risk	1.88	1.18	+0.69
Omega ratio: Gain probability vs. loss probability	1.22	1.13	+0.09
Calmar ratio: Return relative to maximum drawdown	1.76	0.85	+0.91
Martin ratio: Return relative to average drawdown	6.23	1.94	+4.29

UXI vs. CURE - Sharpe Ratio Comparison

The current UXI Sharpe Ratio is 1.29, which is higher than the CURE Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of UXI and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

UXI vs. CURE - Drawdown Comparison

The maximum UXI drawdown since its inception was -89.01%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for UXI and CURE.

Drawdown Indicators

	UXI	CURE	Difference
Max Drawdown Largest peak-to-trough decline	-89.01%	-69.19%	-19.82%
Max Drawdown (1Y) Largest decline over 1 year	-23.59%	-31.10%	+7.51%
Max Drawdown (3Y) Largest decline over 3 years	-36.42%	-51.93%	+15.51%
Max Drawdown (5Y) Largest decline over 5 years	-48.25%	-52.23%	+3.98%
Max Drawdown (10Y) Largest decline over 10 years	-66.48%	-69.19%	+2.71%
Current Drawdown Current decline from peak	-5.56%	-26.94%	+21.38%
Average Drawdown Average peak-to-trough decline	-22.58%	-18.16%	-4.42%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.67%	13.71%	-7.04%

Volatility

UXI vs. CURE - Volatility Comparison

The current volatility for ProShares Ultra Industrials (UXI) is 12.20%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 14.30%. This indicates that UXI experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UXI	CURE	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.20%	14.30%	-2.10%
Volatility (6M) Calculated over the trailing 6-month period	27.14%	30.87%	-3.73%
Volatility (1Y) Calculated over the trailing 1-year period	32.32%	44.32%	-12.00%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	36.13%	43.84%	-7.71%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	39.52%	49.59%	-10.07%

UXI vs. CURE - Expense Ratio Comparison

UXI has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.

Dividends

UXI vs. CURE - Dividend Comparison

UXI's dividend yield for the trailing twelve months is around 0.66%, less than CURE's 1.16% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CURE Direxion Daily Healthcare Bull 3x Shares	1.16%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%	0.00%	0.00%
UXI ProShares Ultra Industrials	0.66%	0.90%	0.18%	0.21%	0.24%	0.03%	0.29%	0.58%	0.37%	0.24%	0.38%	0.41%

Frequently Asked Questions

Can I hold both UXI and CURE in my portfolio?

UXI and CURE have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, UXI or CURE?

CURE has higher volatility (14.30%) compared to UXI (12.20%). In terms of maximum drawdown, UXI dropped -89.01% vs CURE's -69.19%.

Which ETF is better, UXI or CURE?

On 10-year performance, UXI leads with 19.65% vs 13.49% for CURE. On fees, UXI is cheaper at 0.95% per year. On volatility, UXI has been the lower-risk option at 12.20%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, UXI or CURE?

Over the 10-year period, UXI has performed better with a 19.65% return vs 13.49%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, UXI or CURE?

UXI is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.

Which ETF pays a higher dividend yield, UXI or CURE?

CURE has the higher dividend yield at 1.16%, compared with 0.66% for UXI.

What is the main difference between UXI and CURE?

UXI tracks Dow Jones U.S. Industrials Index (200%), while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for UXI and 1.08% for CURE.

Which has better risk-adjusted returns?

UXI currently has the higher Sharpe Ratio (1.29 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.